Delivery Order SPE2DB24D2216-SPE2DB25FGPSE
- Not listed
- The Defense Logistics Agency awarded a $2,816.02 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,702.41 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The contract carries no set-aside designation and was competitively awarded. Performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Rabavert rabies vaccine with diluents. This firm fixed price delivery order, valued at $2,840.90, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $2,095.80 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rabavert rabies vaccine with diluents, valued at $18,968.07. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), represents a non-competitive set-aside procurement. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,149.60 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 20, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under a firm fixed price structure, providing the federal government with...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs through AmerisourceBergen's established vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.40 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. The contract is firm fixed price with no set-aside designation and was competitively awarded on August 29, 2025, with an ultimate completion date of September 2, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPSEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,029.92 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed price delivery order utilizes no set-aside provisions and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies supporting military healthcare systems globally, including specialty medications, vaccines, and related medical commodities across multiple therapeutic areas. The contract demonstrates the company's critical role as a pharmaceutical distributor for federal medical procurement, serving the Defense Health Agency and other government healthcare entities through a flexible delivery order mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/29/25 |